Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 22372560)

1.

Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures.

Gisbert JP, Castro-Fernandez M, Perez-Aisa A, Cosme A, Molina-Infante J, Rodrigo L, Modolell I, Cabriada JL, Gisbert JL, Lamas E, Marcos E, Calvet X.

Aliment Pharmacol Ther. 2012 Apr;35(8):941-7. doi: 10.1111/j.1365-2036.2012.05053.x. Epub 2012 Feb 28.

PMID:
22372560
2.

Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection.

Gisbert JP, Perez-Aisa A, Rodrigo L, Molina-Infante J, Modolell I, Bermejo F, Castro-Fernández M, Antón R, Sacristán B, Cosme A, Barrio J, Harb Y, Gonzalez-Barcenas M, Fernandez-Bermejo M, Algaba A, Marín AC, McNicholl AG; H. pylori Study Group of the Spanish Gastroenterology Association.

Dig Dis Sci. 2014 Feb;59(2):383-9. doi: 10.1007/s10620-013-2900-x. Epub 2013 Oct 15.

PMID:
24126798
3.

'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures.

Gisbert JP, Calvet X, Bujanda L, Marcos S, Gisbert JL, Pajares JM.

Helicobacter. 2003 Apr;8(2):90-4.

PMID:
12662375
4.

Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.

Gisbert JP, Molina-Infante J, Marin AC, Vinagre G, Barrio J, McNicholl AG.

Scand J Gastroenterol. 2013 Jun;48(6):652-6. doi: 10.3109/00365521.2013.786132. Epub 2013 Apr 5.

PMID:
23556551
5.

Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy.

Gisbert JP, Barrio J, Modolell I, Molina-Infante J, Aisa AP, Castro-Fernández M, Rodrigo L, Cosme A, Gisbert JL, Fernández-Bermejo M, Marcos S, Marín AC, McNicholl AG.

Dig Dis Sci. 2015 Feb;60(2):458-64. doi: 10.1007/s10620-014-3365-2. Epub 2014 Sep 19.

PMID:
25236423
6.

Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures.

Gisbert JP, Gisbert JL, Marcos S, Moreno-Otero R, Pajares JM.

Aliment Pharmacol Ther. 2006 Nov 15;24(10):1469-74. Epub 2006 Oct 10.

7.

Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.

Gisbert JP, Castro-Fernández M, Bermejo F, Pérez-Aisa A, Ducons J, Fernández-Bermejo M, Bory F, Cosme A, Benito LM, López-Rivas L, Lamas E, Pabón M, Olivares D; H. pylori Study Group of the Asociación Española de Gastroenterología.

Am J Gastroenterol. 2006 Feb;101(2):243-7.

PMID:
16454825
8.

Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients.

Gisbert JP, Bermejo F, Castro-Fernández M, Pérez-Aisa A, Fernández-Bermejo M, Tomas A, Barrio J, Bory F, Almela P, Sánchez-Pobre P, Cosme A, Ortiz V, Niño P, Khorrami S, Benito LM, Carneros JA, Lamas E, Modolell I, Franco A, Ortuño J, Rodrigo L, García-Durán F, O'Callaghan E, Ponce J, Valer MP, Calvet X; H. pylori Study Group of the Asociación Española de Gastroenterología.

Am J Gastroenterol. 2008 Jan;103(1):71-6. Epub 2007 Aug 31.

PMID:
17764498
9.

Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.

Gisbert JP, Gisbert JL, Marcos S, Jimenez-Alonso I, Moreno-Otero R, Pajares JM.

Aliment Pharmacol Ther. 2008 Feb 15;27(4):346-54. Epub 2007 Nov 12.

10.

Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatments.

Gisbert JP, Gisbert JL, Marcos S, Pajares JM.

Dig Liver Dis. 2004 Jan;36(1):7-12.

PMID:
14971810
11.

Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients.

Gisbert JP, Pérez-Aisa A, Bermejo F, Castro-Fernández M, Almela P, Barrio J, Cosme A, Modolell I, Bory F, Fernández-Bermejo M, Rodrigo L, Ortuño J, Sánchez-Pobre P, Khorrami S, Franco A, Tomas A, Guerra I, Lamas E, Ponce J, Calvet X; H. pylori Study Group of the Asociación Española de Gastroenterología (Spanish Gastroenterology Association).

J Clin Gastroenterol. 2013 Feb;47(2):130-5. doi: 10.1097/MCG.0b013e318254ebdd.

PMID:
22647827
12.

Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.

Uygun A, Kadayifci A, Yesilova Z, Safali M, Ilgan S, Karaeren N.

Clin Ther. 2008 Mar;30(3):528-34. doi: 10.1016/j.clinthera.2008.03.009.

PMID:
18405790
13.

Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.

Bardhan KD, Morton D, Perry MJ, Sanders DS, Morris P, Rowland A, Thompson M, Mitchell TR, Roberts PM.

Aliment Pharmacol Ther. 2001 Aug;15(8):1199-204.

14.

Helicobacter pylori: usefulness of an empirical fourth-line rifabutin-based regimen.

D'Elios MM, Silvestri E, Emmi G, Barnini T, Prisco D.

Expert Rev Gastroenterol Hepatol. 2012 Aug;6(4):437-9. doi: 10.1586/egh.12.32.

PMID:
22928895
15.
16.

Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin.

Gisbert JP, Gisbert JL, Marcos S, Olivares D, Pajares JM.

Aliment Pharmacol Ther. 2005 Nov 15;22(10):1041-6.

17.

[Comparison of rifabutin- and levofloxacin-based third-line rescue therapies for Helicobacter pylori].

Jeong MH, Chung JW, Lee SJ, Ha M, Jeong SH, Na S, Na BS, Park SK, Kim YJ, Kwon KA, Ko KI, Jo Y, Hahm KB, Jung HY.

Korean J Gastroenterol. 2012 Jun 25;59(6):401-6. Korean.

18.

Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.

Borody TJ, Pang G, Wettstein AR, Clancy R, Herdman K, Surace R, Llorente R, Ng C.

Aliment Pharmacol Ther. 2006 Feb 15;23(4):481-8. Erratum in: Aliment Pharmacol Ther. 2006 Jul 15;24(2):439.

19.

Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.

Almeida N, Romãozinho JM, Donato MM, Luxo C, Cardoso O, Cipriano MA, Marinho C, Sofia C.

Helicobacter. 2014 Apr;19(2):90-7. doi: 10.1111/hel.12106. Epub 2014 Feb 10.

PMID:
24506175
20.

First-line triple therapy with levofloxacin for Helicobacter pylori eradication.

Gisbert JP, Fernández-Bermejo M, Molina-Infante J, Pérez-Gallardo B, Prieto-Bermejo AB, Mateos-Rodríguez JM, Robledo-Andrés P, González-García G.

Aliment Pharmacol Ther. 2007 Aug 1;26(3):495-500.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk